The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy

Routes of Delivery for CpG and Anti-CD137 for the Treatment of Orthotopic Kidney Tumors in Mice

(2014) Jennifer A. Westwood et al.   PLoS One

Impact of aging in cancer immunotherapy

(2014) Myriam N Bouchlaka et al.   OncoImmunology

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+T cells

(2014) Debbie C Strachan et al.   OncoImmunology

Animal models of disease: Pre-clinical animal models of cancer and their applications and utility in drug discovery

(2013) Bruce A. Ruggeri et al.   BIOCHEMICAL PHARMACOLOGY

Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy

(2013) Christel Devaud et al.   MOLECULAR THERAPY

The role of tumour–stromal interactions in modifying drug response: challenges and opportunities

(2013) Douglas W. McMillin et al.   NATURE REVIEWS DRUG DISCOVERY

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment

(2013) Michael H Kershaw et al.   OncoImmunology

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

(2013) Christel Devaud et al.   OncoImmunology

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

(2010) Jennifer A Westwood et al.   Journal of Translational Medicine

Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice

(2009) J. A. Westwood et al.   CLINICAL CANCER RESEARCH